Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study - PubMed (original) (raw)
Comparative Study
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study
G Perseghin et al. Diabetes. 1997 Jun.
Abstract
First-degree relatives of NIDDM patients have an approximately 40% lifetime risk of developing diabetes, and insulin resistance is the best predictor. However, insulin resistance is altered by many other factors, including age, diet, exercise, and medications. To investigate the metabolic and endocrine alterations associated with insulin resistance when all the above confounding factors are excluded, we examined the first phase of insulin secretion and insulin sensitivity in 49 white normoglycemic (4.99 +/- 0.51 vs. 4.95 +/- 0.41 mmol/l) nonexercising lean (BMI, 24 +/- 3 vs. 23 +/- 2 kg/m2; 105 +/- 3 vs. 104 +/- 3% of ideal body weight) offspring of NIDDM patients. These subjects were compared with 29 matched healthy control subjects by means of an intravenous glucose bolus (0.3 g/kg body wt), immediately followed by a euglycemic-hyperinsulinemic (approximately 420 pmol/l) clamp, along with lipid and amino acid profiles. The offspring showed fasting hyperinsulinemia (40.6 +/- 15.8 vs. 30.9 +/- 13.6 pmol/l; P = 0.005) and higher free fatty acid (FFA) levels (582 +/- 189 vs. 470 +/- 140 micromol; P = 0.007), whereas triglycerides, total cholesterol, and HDL and LDL cholesterol levels were comparable with those of control subjects. Alanine (320 +/- 70 vs. 361 +/- 73 micromol/l; P = 0.017), serine (P = 0.05), and glutamine and glycine (P = 0.02) were lower in the offspring than in the control subjects, whereas branched-chain amino acids (343 +/- 54 vs. 357 +/- 54 micromol/l; P = 0.28) were not different. Insulin sensitivity was lower (4.86 +/- 1.65 vs. 6.17 +/ 1.56 mg x kg(-1) x min(-1); P = 0.001), and an inverse correlation with fasting FFAs in the offspring (adjusted R2 = 0.21, P = 0.0005), but not in control subjects (adjusted R2 = 0.03, P = 0.368), was found. Because insulin sensitivity in the offspring appeared to be a mixture of three distributions, they were subdivided into three subgroups: very low, low, and normal insulin sensitivity (20, 47, and 33%, respectively). The same alterations in amino acid and FFA metabolism were observed in the very low and low subgroups but not in the normal subgroup. The first phase of insulin secretion appeared to compensate significantly for insulin resistance in the low subgroup versus the normal subgroup and controls, but was inappropriately low in the subgroup with very low insulin sensitivity considering its degree of insulin resistance. In conclusion, lean insulin-resistant offspring of NIDDM parents showed 1) trimodal distribution of insulin sensitivity, 2) high fasting plasma FFA concentrations, 3) an inverse correlation between insulin sensitivity and FFA concentration, 4) low plasma gluconeogenic amino acid concentrations, and 5) defective insulin secretion when related to insulin sensitivity in the subgroup of very resistant offspring. These results suggest that, in this white population, insulin sensitivity may be determined by a single major gene and that alterations in FFA metabolism may play a role in the pathogenesis of NIDDM.
Similar articles
- Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H. Halberstam M, et al. Diabetes. 1996 May;45(5):659-66. doi: 10.2337/diab.45.5.659. Diabetes. 1996. PMID: 8621019 Clinical Trial. - Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.
Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M. Vauhkonen I, et al. J Clin Invest. 1998 Jan 1;101(1):86-96. doi: 10.1172/JCI716. J Clin Invest. 1998. PMID: 9421470 Free PMC article. - Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H. Henriksen JE, et al. Diabetes. 2000 Jul;49(7):1209-18. doi: 10.2337/diabetes.49.7.1209. Diabetes. 2000. PMID: 10909980 - In vivo glucose metabolism, insulin secretion and, insulin action in Europids with non-insulin-dependent diabetes mellitus (NIDDM) and their first-degree relatives.
Beck-Nielsen H, Henriksen JE, Alford F, Hother-Nielson O. Beck-Nielsen H, et al. Diabet Med. 1996 Sep;13(9 Suppl 6):S78-84. Diabet Med. 1996. PMID: 8894487 Review. - Type 2 diabetes or NIDDM: looking for a better name.
[No authors listed] [No authors listed] Lancet. 1989 Mar 18;1(8638):589-91. Lancet. 1989. PMID: 2564114 Review. No abstract available.
Cited by
- Endothelial Dysfunction in Obesity and Therapeutic Targets.
Engin A. Engin A. Adv Exp Med Biol. 2024;1460:489-538. doi: 10.1007/978-3-031-63657-8_17. Adv Exp Med Biol. 2024. PMID: 39287863 Review. - Assessing the Impact of Bariatric Surgery on Retinol-Binding Protein 4 (RBP4): A Systematic Review and Meta-Analysis.
Bidares M, Safari-Kish B, Malekzadeh-Shoushtari H, Azarbayejani N, Nosouhi G, Aziz M. Bidares M, et al. Obes Surg. 2024 May;34(5):1855-1865. doi: 10.1007/s11695-024-07140-5. Epub 2024 Mar 7. Obes Surg. 2024. PMID: 38451368 Review. - Metabolic syndrome and obesity among marginalised school-going adolescents in Karachi, Pakistan: a cross-sectional study.
Sharif H, Sheikh SS, Seemi T, Naeem H, Khan U, Jan SS. Sharif H, et al. Lancet Reg Health Southeast Asia. 2024 Jan 30;21:100354. doi: 10.1016/j.lansea.2024.100354. eCollection 2024 Feb. Lancet Reg Health Southeast Asia. 2024. PMID: 38322154 Free PMC article. - Applying a modified systematic review and integrated assessment framework (SYRINA) - a case study on triphenyl phosphate.
Bui TT, Aasa J, Abass K, Ågerstrand M, Beronius A, Castro M, Escrivá L, Galizia A, Gliga A, Karlsson O, Whaley P, Yost E, Rudén C. Bui TT, et al. Environ Sci Process Impacts. 2024 Feb 21;26(2):380-399. doi: 10.1039/d3em00353a. Environ Sci Process Impacts. 2024. PMID: 38205707 Free PMC article. Review. - Partners in diabetes epidemic: A global perspective.
Wang H, Akbari-Alavijeh S, Parhar RS, Gaugler R, Hashmi S. Wang H, et al. World J Diabetes. 2023 Oct 15;14(10):1463-1477. doi: 10.4239/wjd.v14.i10.1463. World J Diabetes. 2023. PMID: 37970124 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- R01 DK040936/DK/NIDDK NIH HHS/United States
- M01 RR-00125/RR/NCRR NIH HHS/United States
- P30 DK-45735/DK/NIDDK NIH HHS/United States
- R01 DK-49230/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous